title: [New and "old" antiretroviral drugs in Pediatrics: new doses, formulations and associations].
abstract: Of the 25 antiretroviral drugs available in the market, only 16 are allowed for prescription in the pediatric patients. The antiretroviral, pertaining to the first three families, used for two decades, remain valid and are important components of antiretroviral therapy in naive children. We describe doses, presentations and current associations for these drugs in children, and also discuss new co-formulations that will reduce the number of doses, improve tolerance and therefore achieve better adherence of pediatric patients.
authors.affiliation: Hospital Clinico Dr. Félix Bulnes Cerda, Santiago, Chile. Servicio de Pediatria. Comité Nacional de SIDA Pediátrico. julia.villarroel@vtr.net
authors.forename: Julia
authors.initials: J
authors.lastname: Villarroel B
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D019380:Anti-HIV Agents / Q000008:administration & dosage; D044966:Anti-Retroviral Agents / Q000008:administration & dosage*; D002648:Child; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage; D054303:HIV Reverse Transcriptase / Q000037:antagonists & inhibitors; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage
chemical_list: D019380:Anti-HIV Agents; D044966:Anti-Retroviral Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D054303:HIV Reverse Transcriptase